Table 1.
Biospecimen sources for application of metabolomics in TBI research
| Biospecimen | Pros | Cons |
|---|---|---|
| Tissue | The most direct relevance to the injury, can compare injured hemisphere to uninjured hemisphere | Not applicable to clinical research; rarely would tissue be available and unclear how a metabolomics study could be designed |
| Blood | Easily obtained | Systemic vs. Brain |
| Arteriovenous differences | Systemic minus cerebral metabolites | Jugular catheter is invasive |
| Cerebrospinal fluid | Drained as a treatment for high intracranial pressure, would otherwise be discarded | Commonly available with severe injuries; invasive to obtain otherwise |
| Urine | Easily obtained | Concentration of metabolites a function of systemic dilution; within sample normalization is common |
| Cerebral microdialysate | From the cerebral tissue, as close to the source as possible | Low volumes obtained leading to pooling biofluid over a large periods of time; perfusate and not directly sampling extracellular fluid |